
In this retrospective single-center study, we evaluated the impact of a modified Access, Watch, and Reserve (AWaRe) calculation method on outpatient oral antibiotic use at a 490-bed tertiary care hospital in Japan in 2025. We compared AWaRe proportions and antibiotic class-specific defined daily doses (DDDs) between the conventional and modified methods and characterized the diagnoses associated with DDD reductions attributable to the modified method. Under the modified method, long-term prescriptions of macrolides, quinolones, tetracyclines, and trimethoprim-sulfamethoxazole were converted to 14-d equivalents, and the total amount of rifaximin prescribed was set to zero. Among 2,326 outpatients who received oral antibiotics, 1,424 received at least one antibiotic affected by the modified method. The Access proportion increased from 28.1% to 46.5% (p < 0.01), whereas the Watch proportion decreased from 71.3% to 51.9% (p < 0.01). Of the DDD reductions after long-term prescription adjustment, 70.7% were associated with conditions whose long-term antibiotic treatment or prophylaxis is supported by clinical guidelines or previous studies. In conclusion, the modified AWaRe calculation method reduces the influence of rifaximin use and long-term antibiotic prescriptions on outpatient AWaRe proportions. However, diagnosis-based interpretation of reductions in DDDs, particularly for tetracyclines, requires further investigation.
Fruquintinib (FRU) is a vascular endothelial growth factor receptor (VEGFR)-1, 2, 3 tyrosine kinase inhibitor (TKI) approved for metastatic colorectal cancer. While hypertension, fatigue, and hand-foot syndrome are common adverse events, severe proteinuria and nephrotic syndrome are rare and has not been reported in clinical trials. A woman in her 60s with recurrent rectal cancer began fruquintinib at 5 mg/d as a 4th-line treatment. She had a history of hypertension and was taking amlodipine. On day 8 of the first cycle, she developed hypertension (grade 2) . On day 22, proteinuria (grade 3) was detected and hypertension had worsened (grade 3) . Since these changes occurred during the off-treatment period, observation was selected. However, on day 23, the patient presented with fatigue, generalized edema, and dyspnea. Laboratory tests revealed a urine protein/creatinine ratio of 10.3 g/gCr and elevated serum creatinine (grade 1), leading to hospitalization. Post-admission, hypermagnesemia (grade 3) was also noted. loxoprofen and magnesium oxide were discontinued and furosemide was initiated. By day 6 of hospitalization, 24-h urine protein quantification had decreased to 2.1 g/d. By day 9, edema and hypertension had both improved, and the patient was discharged. The Naranjo score were 7 for fruquintinib, 6 for loxoprofen and bevacizumab, and 5 for trifluridine/tipiracil hydrochloride, suggesting probable adverse drug reaction. VEGFR-TKIs are presumed to impair glomerular structure and function, leading to proteinuria. Although renal biopsy was not performed, thrombocytopenia and elevated lactate dehydrogenase suggested thrombotic microangiopathy. Earlier monitoring could have enabled faster detection and prevention of severe symptoms.
A woman in her 80s was diagnosed with colon cancer, and she underwent chemotherapy after surgery. Oxycodone extended-release tablets were initiated for abdominal pain, but oral administration was difficult, leading to a change to fentanyl patches. Owing to severe numbness from the buttocks to the toes, tramadol/acetaminophen (T/A) tablets were initiated at a dose of 2 tablets per day. The fentanyl patch dose was increased to 2 mg/d, and pain was relieved on combination with 2 T/A tablets. The patient subsequently reported behavioral disturbances, including agitation, anxiety, and sudden diarrhea. She had been taking 1 T/A tablet 2 to 3 times per day at her discretion when the pain worsened. Suspecting an additive effect from the combination of the fentanyl patch and T/A tablets, the T/A tablets were immediately discontinued, and the symptoms resolved. Loxoprofen tablets were initiated at 180 mg/d, and the fentanyl patch dose was increased to 4 mg/d, without side effects such as agitation, anxiety, or behavioral disorders. The combined use of tramadol and fentanyl likely induced excessive serotonergic activity; careful observation is required in adult patients and those receiving multiple medications.
For this study, we defined "mental health support at pharmacies" as "mental support and reassurance through explanations for medications and illnesses, and health consultations," which are not difficult from a mental health perspective, and conducted a survey on how pharmacies can contribute to mental health in local residents (n = 580). However, according to this definition, 80.3% answered that they had not received "mental health support at pharmacies." We then asked 77 people who had experienced "mental health support at pharmacies" when they had obtained this support. The answers received were "explanations of prescription medication" (46.8%) and "explanations of over-the-counter drugs [OTC drugs and pharmacist intervention required drugs (yo-shido-iyakuhin)]" (31.2%) during the pharmacy's main duties. Furthermore, in the survey of all 580 residents, the "initiatives that would be good to have in pharmacies to support mental health" were "mental health check" (31.2%), "explanations of prescription medication" (30.2%). Moreover, regardless of whether there were difficulties with mental health, the reasons given by the 55 people who answered that pharmacies should not be involved in mental health were "mental health is-difficult as a specialty" (52.7%) and "mental health is difficult in terms of personal information" (43.6%). Therefore, it is suggested that pharmacy pharmacists should initially provide "mental health support" at pharmacies for mental health areas that do not require specialist knowledge.
Active learning methods, such as team- and problem-based learning, are known to improve students' learning attitudes and teamwork skills in undergraduate education. This study conducted an experiment that incorporated an escape room (ER) in classes with the aim of improving students' motivation to learn and knowledge acquisition through collaborative learning. An ER was designed and administered to third-year undergraduate pharmacy students. Students were randomly assigned to a control group (regular lecture focused on knowledge transfer) or an ER group. Both groups completed pre- and post-tests. Learning outcomes and educational usefulness were evaluated using statistical analyses (t-test and chi-squared test) and text mining. The ER group had significantly higher average post-test scores compared with the control group, particularly in terms of new knowledge acquisition. The results of the questionnaire survey, which included free-form responses, indicated improvements in enjoyment, concentration, and motivation to learn. The ER provided opportunities for collaborative, active learning and demonstrated significant benefits in knowledge acquisition and educational usefulness, including increased motivation. These results could be attributed partly to the fact that ER provides a learning experience combining challenge and a sense of accomplishment, leading to a flow-like psychological state. Therefore, ER demonstrates its potential as an effective method of knowledge education in pharmacy education. Future research can clarify the effectiveness of ER by further examining the conditions that maximize the learning benefits of ER, such as the learning effects of review content and its application to other pharmacy-related subjects.